المؤلفون: Fortner RT; Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Majorstuen, Postbox 5313, 0304, Oslo, Norway. Renee.Turzanski.Fortner@kreftregisteret.no.; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. Renee.Turzanski.Fortner@kreftregisteret.no., Brantley KD; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Tworoger SS; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Tamimi RM; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Rosner B; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Holmes MD; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Willett WC; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Eliassen AH; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jul; Vol. 206 (1), pp. 77-90. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/epidemiology , Breast Neoplasms*/etiology , Exercise* , Receptors, Progesterone*/metabolism , Receptors, Estrogen*/metabolism , Menopause*, Humans ; Female ; Middle Aged ; Adult ; Risk Factors ; Nurses/statistics & numerical data ; Recreation ; Postmenopause ; Premenopause ; Proportional Hazards Models

المؤلفون: Coombes RC; Imperial College London, South Kensington Campus, London, SW7 2AZ, UK., Angelou C; Imperial College London, South Kensington Campus, London, SW7 2AZ, UK., Al-Khalili Z; Imperial College London, South Kensington Campus, London, SW7 2AZ, UK., Hart W; Imperial College London, South Kensington Campus, London, SW7 2AZ, UK., Francescatti D; Rush Medical College, Chicago, USA., Wright N; Barts Cancer Institute, London, UK., Ellis I; Nottingham University Hospital, Nottingham, UK., Green A; Nottingham University Hospital, Nottingham, UK., Rakha E; Nottingham University Hospital, Nottingham, UK., Shousha S; Imperial College London, South Kensington Campus, London, SW7 2AZ, UK., Amrania H; Imperial College London, South Kensington Campus, London, SW7 2AZ, UK. Hemmel.amrania@imperial.ac.uk., Phillips CC; Imperial College London, South Kensington Campus, London, SW7 2AZ, UK., Palmieri C; University of Liverpool, Liverpool, UK.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 349-358. Date of Electronic Publication: 2024 Jan 20.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Breast Neoplasms*/drug therapy , Breast Neoplasms*/mortality , Breast Neoplasms*/therapy , Receptors, Estrogen*/metabolism , Receptors, Progesterone*/metabolism, Humans ; Female ; Middle Aged ; Aged ; Adult ; Prognosis ; Receptor, ErbB-2/metabolism ; Chemotherapy, Adjuvant/methods ; Clinical Decision-Making ; Neoplasm Recurrence, Local/pathology ; Kaplan-Meier Estimate ; Proportional Hazards Models ; Aged, 80 and over

المؤلفون: Guo D; School of Social Development and Public Policy, Beijing Normal University, 19 Xinjiekouwai Street, Beijing, 100875, China., Hendryx M; Department of Environmental and Occupational Health, School of Public Health, Indiana University Bloomington, 1025 E 7th street, Bloomington, IN, 47405, USA., Liang X; School of Social Development and Public Policy, Beijing Normal University, 19 Xinjiekouwai Street, Beijing, 100875, China. liangxiaoyun@bnu.edu.cn., Manson JE; Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue, 3rd Fl, Boston, MA, 02215, USA., He K; Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, 622 W. 168th Street, New York, NY, 10032, USA., Vitolins MZ; Department of Epidemiology and Prevention, School of Medical, Wake Forest University, 475 Vine Street, Winston-Salem, NC, 27157, USA., Li Y; Department of Dermatology, Brown Alpert Medical School, 336 Eddy Street, Providence, RI, 02903, USA., Luo J; Department of Epidemiology and Biostatistics, School of Public Health, Indiana University Bloomington, 1025 E 7th street, Bloomington, IN, 47405, USA.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Aug; Vol. 183 (1), pp. 217-226. Date of Electronic Publication: 2020 Jun 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Estrogens* , Progesterone* , Selenium* , Women's Health*, Breast Neoplasms/*epidemiology , Health Surveys/*statistics & numerical data , Neoplasms, Hormone-Dependent/*epidemiology, Aged ; Breast Neoplasms/chemistry ; Breast Neoplasms/prevention & control ; Diet ; Dietary Supplements ; Female ; Follow-Up Studies ; Humans ; Incidence ; Middle Aged ; Neoplasm Proteins/analysis ; Neoplasms, Hormone-Dependent/chemistry ; Neoplasms, Hormone-Dependent/prevention & control ; Postmenopause ; Proportional Hazards Models ; Receptors, Estrogen/analysis ; Receptors, Progesterone/analysis ; Risk Factors ; Surveys and Questionnaires

المؤلفون: Martínez-Jañez N; Medical Oncology Department, Ramon y Cajal University Hospital, Hospital Ramón y Cajal, Ctra. de Colmenar Viejo km. 9,100, Madrid, 28034, Spain., Ezquerra MB; Oncology Department, Vall d'Hebron Institute of Oncology (VHIO)-Cellex Center, Barcelona, Spain., Manso Sanchez LM; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Carrasco FH; Oncology, Hospital Universitario Virgen Macarena, Seville, Spain., Torres AA; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Morales S; Medical Oncology Department, Hospital Arnau de Vilanova - Lleida, Alpicat, Spain., Ortega PT; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Gil VLO; Breast Cancer Unit, ICO - Institut Català d'Oncologia l'Hospitalet (Hospital Duran i Reynals) L'Hospitalet De, Llobregat, Spain., Sampedro T; Medical Oncology Department, Hospital Universitario de Cabuenes, Gijón, Spain., Conejero RA; Medical Oncology Department, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain., Calvo-Martinez L; Medical Oncology Department, CHUAC - Complexo Hospitalario Universitario A Coruña, A Coruña, Spain., Galve-Calvo E; Medical Oncology Department, Hospital Universitario de Basurto, Bilbao, Spain., López R; Servicio de Oncología Médica y Grupo de Oncología Médica Traslacional, Hospital Clínico Universitario e Instituto de Investigación Sanitaria-CIBERONC, Santiago de Compostela, Spain., de la Pena FA; Medical Oncology Department, Hospital General Universitario Morales Meseguer, Murcia, Spain., Lopez-Tarruella S; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERONC, Geicam, Universidad Complutense, Madrid, Spain., de Araguiz BAHF; Medical Oncology Department, Complejo Hospitalario de Burgos -Hospital General Yagüe, Burgos, Spain., Ruiz LB; Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Cardenas TM; Medical Oncology Department, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain., Chacon JI; Medical Oncology Department, Hospital Virgen de la Salud, Toledo, Spain., Antón FM; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain. fermor03@ucm.es.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jul; Vol. 206 (2), pp. 317-328. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Pyridines*/therapeutic use , Pyridines*/adverse effects , Pyridines*/administration & dosage , Piperazines*/therapeutic use , Piperazines*/administration & dosage , Piperazines*/adverse effects , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Breast Neoplasms*/metabolism , Receptor, ErbB-2*/metabolism, Humans ; Female ; Middle Aged ; Aged ; Adult ; Male ; Retrospective Studies ; Aged, 80 and over ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/administration & dosage ; Progression-Free Survival

المؤلفون: Finsterbusch K; Department of Surgical Pathology, Dietrich Bonhoeffer Klinikum, Allendestrasse 30, 17033, Neubrandenburg, Germany., van Diest PJ; Department of Pathology, University Medical Centre Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands., Focke CM; Department of Surgical Pathology, Dietrich Bonhoeffer Klinikum, Allendestrasse 30, 17033, Neubrandenburg, Germany. Cornelia.Focke@web.de.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 413-421. Date of Electronic Publication: 2024 Mar 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/metabolism , Immunohistochemistry* , Neoplasm Grading* , Receptors, Estrogen*/metabolism, Humans ; Female ; Receptor, ErbB-2/metabolism ; Receptor, ErbB-2/genetics ; Receptors, Progesterone/metabolism ; Middle Aged ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Adult ; Aged

المؤلفون: van de Loo ME; Department of Surgery, Medical Center Haaglanden, The Hague, The Netherlands., Andour L; Department of Surgery, Medical Center Haaglanden, The Hague, The Netherlands., van Heesewijk AE; Department of Surgery, Medical Center Haaglanden, The Hague, The Netherlands., Oosterkamp HM; Department of Oncology, Medical Center Haaglanden, The Hague, The Netherlands., Liefers GJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Straver ME; Department of Surgery, Medical Center Haaglanden, The Hague, The Netherlands. m.straver@haaglandenmc.nl.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 May; Vol. 205 (1), pp. 5-16. Date of Electronic Publication: 2024 Jan 24.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Hormonal*/therapeutic use , Breast Neoplasms*/surgery , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Mastectomy, Segmental*/methods , Neoadjuvant Therapy*/methods, Female ; Humans ; Chemotherapy, Adjuvant/methods ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Treatment Outcome

المؤلفون: Chen Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Zhang R; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Yan Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Li H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, China. huipingli2012@hotmail.com., Song G; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, China. songguohong918@hotmail.com.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Aug; Vol. 206 (3), pp. 543-550. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism , Premenopause* , Gonadotropin-Releasing Hormone*/agonists , Aromatase Inhibitors*/therapeutic use, Humans ; Female ; Adult ; Retrospective Studies ; Middle Aged ; Ovary/drug effects ; Ovary/metabolism ; Antineoplastic Agents, Hormonal/therapeutic use ; Treatment Outcome ; Receptors, Estrogen/metabolism ; Goserelin/therapeutic use ; Goserelin/administration & dosage ; Leuprolide/therapeutic use ; Leuprolide/administration & dosage ; Receptors, Progesterone/metabolism ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Sánchez-Bayona R; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Lopez de Sa A; Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Jerez Gilarranz Y; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, C/Dr Esquerdo, 46, 28007, Madrid, Spain., Sanchez de Torre A; Medical Oncology, Hospital Universitario Infanta Cristina, Parla, Spain., Alva M; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Echavarria I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, C/Dr Esquerdo, 46, 28007, Madrid, Spain., Moreno F; Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Tolosa P; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Herrero Lopez B; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, C/Dr Esquerdo, 46, 28007, Madrid, Spain., de Luna A; Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Lema L; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Gamez Casado S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, C/Dr Esquerdo, 46, 28007, Madrid, Spain., Madariaga A; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, C/Dr Esquerdo, 46, 28007, Madrid, Spain., Manso L; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Bueno-Muiño C; Medical Oncology, Hospital Universitario Infanta Cristina, Parla, Spain., Garcia-Saenz JA; Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Ciruelos E; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Martin M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, C/Dr Esquerdo, 46, 28007, Madrid, Spain. mmartin@geicam.org.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Aug; Vol. 206 (3), pp. 551-559. Date of Electronic Publication: 2024 May 04.

نوع المنشور: Journal Article; Observational Study; Multicenter Study

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Everolimus*/administration & dosage , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Breast Neoplasms*/metabolism , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Cyclin-Dependent Kinase 4*/antagonists & inhibitors , Cyclin-Dependent Kinase 6*/antagonists & inhibitors , Receptor, ErbB-2*/metabolism, Humans ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Adult ; Receptors, Estrogen/metabolism ; Aged, 80 and over ; Receptors, Progesterone/metabolism ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Tamoxifen/therapeutic use ; Tamoxifen/administration & dosage ; Antineoplastic Agents, Hormonal/therapeutic use ; Antineoplastic Agents, Hormonal/administration & dosage ; Aromatase Inhibitors/therapeutic use ; Aromatase Inhibitors/administration & dosage ; Fulvestrant/administration & dosage ; Fulvestrant/therapeutic use ; Progression-Free Survival ; Androstadienes/administration & dosage ; Androstadienes/therapeutic use ; Disease Progression

المؤلفون: Walter V; Department of Obstetrics and Gynecology, University Hospital Tuebingen, Calwerstraße 7, 72076, Tuebingen, Germany., Fischer C; Department of Obstetrics and Gynecology, University Hospital Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.; Division of Gynecologic Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany., Deutsch TM; Department of Obstetrics and Gynecology, University Hospital Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.; Division of Gynecologic Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany., Ersing C; Department of Obstetrics and Gynecology, University Hospital Tuebingen, Calwerstraße 7, 72076, Tuebingen, Germany., Nees J; Department of Obstetrics and Gynecology, University Hospital Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany., Schütz F; Department of Obstetrics and Gynecology, University Hospital Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany., Fremd C; Division of Gynecologic Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany., Grischke EM; Department of Obstetrics and Gynecology, University Hospital Tuebingen, Calwerstraße 7, 72076, Tuebingen, Germany., Sinn P; Department of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany., Brucker SY; Department of Obstetrics and Gynecology, University Hospital Tuebingen, Calwerstraße 7, 72076, Tuebingen, Germany., Schneeweiss A; Division of Gynecologic Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.; German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hartkopf AD; Department of Obstetrics and Gynecology, University Hospital Tuebingen, Calwerstraße 7, 72076, Tuebingen, Germany., Wallwiener M; Department of Obstetrics and Gynecology, University Hospital Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany. Markus.Wallwiener@med.uni-heidelberg.de.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Aug; Vol. 183 (1), pp. 137-144. Date of Electronic Publication: 2020 Jul 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Estrogens* , Progesterone*, Breast Neoplasms/*chemistry , Neoplasm Proteins/*analysis , Neoplasms, Hormone-Dependent/*chemistry , Receptor, ErbB-2/*analysis , Receptors, Estrogen/*analysis , Receptors, Progesterone/*analysis, Adolescent ; Adult ; Aged ; Antineoplastic Agents, Hormonal/therapeutic use ; Biomarkers, Tumor ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Female ; Follow-Up Studies ; Germany ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Molecular Targeted Therapy ; Neoplasm Metastasis ; Neoplasm Proteins/antagonists & inhibitors ; Neoplasms, Hormone-Dependent/drug therapy ; Neoplasms, Hormone-Dependent/pathology ; Protein Kinase Inhibitors/therapeutic use ; Receptor, ErbB-2/antagonists & inhibitors ; Retrospective Studies ; Young Adult

المؤلفون: Chen L; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Chen Y; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Xie Z; Zhongshan School of Medicine, Sun Yat-sen University, No. 74, ZhongShan Second Road, Guangzhou, 510080, China., Luo J; Molecular Diagnosis and Gene Testing Center, The First Affiliated Hospital, Sun Yat-sen University, No. 58, ZhongShan Second Road, Guangzhou, 510080, China.; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Wang Y; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Zhou J; Molecular Diagnosis and Gene Testing Center, The First Affiliated Hospital, Sun Yat-sen University, No. 58, ZhongShan Second Road, Guangzhou, 510080, China., Huang L; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Li H; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Wang L; Beijing OriginPoly BioTec Co., Ltd, Beijing, China., Liu P; Beijing OriginPoly BioTec Co., Ltd, Beijing, China., Shu M; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Zhang W; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Ke Z; Molecular Diagnosis and Gene Testing Center, The First Affiliated Hospital, Sun Yat-sen University, No. 58, ZhongShan Second Road, Guangzhou, 510080, China. kezunfu@mail.sysu.edu.cn.; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. kezunfu@mail.sysu.edu.cn.; Institute of Precision Medicine, Sun Yat-sen University, Guangzhou, China. kezunfu@mail.sysu.edu.cn.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Aug; Vol. 194 (3), pp. 517-529. Date of Electronic Publication: 2022 Jul 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/diagnosis , Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism , Receptors, Progesterone*/genetics , Receptors, Progesterone*/metabolism, Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Estrogen Receptor alpha/genetics ; Estrogen Receptor alpha/metabolism ; Female ; Humans ; Immunohistochemistry ; Ki-67 Antigen/genetics ; Ki-67 Antigen/metabolism ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism